Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Arch Pharm (Weinheim) ; 348(5): 366-74, 2015 May.
Article in English | MEDLINE | ID: mdl-25820388

ABSTRACT

A series of triazole-containing carbazole derivatives were designed as new anti-acetylcholinesterase (AChE) agents. The target compounds 6a-q were simply prepared via a one-pot three-component click reaction of N-propargyl-9H-carbazole, sodium azide, and an appropriate benzyl halide. The in vitro anti-cholinesterase assay showed that the unsubstituted benzyl derivative 6p along with the 2-F, 2-Me, 3-Me, 3-MeO, and 3-F analogs (6a, 6c, and 6g-i) had significant anti-AChE activity (IC50s ≤ 3.8 µM). Among them, the 2-methylbenzyl derivative 6c with an IC50 value of 1.9 µM was the most active compound. The SAR studies revealed that small halogen atoms such as the fluorine atom or electron-donating groups such as methyl or methoxy at the ortho or meta positions of the benzyl pendent group could be tolerated or improved the anti-AChE activity.


Subject(s)
Carbazoles/pharmacology , Cholinesterase Inhibitors/pharmacology , Triazoles/pharmacology , Acetylcholinesterase/metabolism , Binding Sites , Carbazoles/chemical synthesis , Carbazoles/metabolism , Cholinesterase Inhibitors/chemical synthesis , Cholinesterase Inhibitors/metabolism , Drug Design , Kinetics , Ligands , Molecular Docking Simulation , Molecular Structure , Protein Binding , Structure-Activity Relationship , Triazoles/chemical synthesis , Triazoles/metabolism
2.
Eur J Med Chem ; 89: 296-303, 2015 Jan 07.
Article in English | MEDLINE | ID: mdl-25462245

ABSTRACT

A new series of tacrine-based acetylcholinesterase (AChE) inhibitors 7a-l were designed by replacing the benzene ring of tacrine with aryl-dihydropyrano[2,3-c]pyrazole. The poly-functionalized hybrid molecules 7a-l were efficiently synthesized through multi-component reaction and subsequent Friedländer reaction between the obtained pyrano[2,3-c]pyrazoles and cyclohexanone. Most of target compounds showed potent and selective anti-AChE activity at sub-micromolar range. The most potent compound 7h bearing a 3,4-dimethoxyphenyl group was more active than reference drug tacrine. The representative compound 7h could significantly protect neurons against oxidative stress as potent as quercetin at low concentrations. The docking study of compound 7h with AChE enzyme revealed that the (R)-enantiomer binds preferably to CAS while the (S)-enantiomer prone to be a PAS binder.


Subject(s)
Cholinesterase Inhibitors/chemical synthesis , Heterocyclic Compounds, 4 or More Rings/chemical synthesis , Neuroprotective Agents/chemical synthesis , Pyrans/chemistry , Pyrazoles/chemistry , Tacrine/analogs & derivatives , Tacrine/chemical synthesis , Animals , Butyrylcholinesterase/blood , Cell Death/drug effects , Cholinesterase Inhibitors/chemistry , Cholinesterase Inhibitors/pharmacology , Drug Design , Electrophorus , Heterocyclic Compounds, 4 or More Rings/chemistry , Heterocyclic Compounds, 4 or More Rings/pharmacology , Horses , Hydrogen Peroxide/pharmacology , Kinetics , Molecular Docking Simulation , Neuroprotective Agents/chemistry , Neuroprotective Agents/pharmacology , PC12 Cells , Rats , Tacrine/chemistry , Tacrine/pharmacology
3.
Daru ; 22: 83, 2014 Dec 24.
Article in English | MEDLINE | ID: mdl-25539909

ABSTRACT

BACKGROUND: Breast cancer is the most common type of female cancer. One class of hormonal therapy for breast cancer drugs -non steroidal aromatase inhibitors- are triazole analogues. In this work, some derivatives of these drugs was designed and synthesized. All synthesized compounds were evaluated for their cytotoxic activities on breast cancer cell lines (MDA-MB-231, T47D and MCF-7). METHODS: Our synthetic route for designed compounds started from 4-bromotolunitrile which was reacted with 1H-1,2,4-triazole to afford 4-(4-cyanobenzyl)-1,2,4-triazole. The reaction of later compound with aromatic aldehydes led to formation of the designed compounds. Eleven novel derivatives 1a-k were tested for their cytotoxic activities on three human breast cancer cell lines. RESULTS: Among the synthesized compound, 4-[2-(3-chlorophenyl)-1-(1H-1,2,4-triazol-1-yl)ethenyl]benzonitrile (1c) showed the highest activity against MCF-7 and MDA-MB-231 cell lines and 4-[2-(4-methoxyphenyl)-1-(1H-1,2,4-triazol-1-yl)ethenyl]benzonitrile (1 h) exhibited highest activity against T47D cell line. According to cytotoxic activities results, compound 4-[2-(4-dimethylamino)-1-(1H-1,2,4-triazol-1-yl)ethenyl]benzonitrile (1 k) showed comparative activity against T47D and MDA-MB-231 cell lines with compound (1 h) and our reference drug Etoposide. CONCLUSION: In the process of anti-cancer drug discovery, to find new potential anti-breast cancer agents, we designed and synthesized a novel series of letrozole analogs. Cytotoxicity evaluation revealed that compounds (1c) and (1 k) were the most potent compounds with comparative activity with Etoposide. The results revealed that π-π interactions are responsible for the enzyme inhibitions of compounds (1 c) and (1 k).


Subject(s)
Antineoplastic Agents, Hormonal/chemical synthesis , Antineoplastic Agents, Hormonal/pharmacology , Aromatase Inhibitors/chemical synthesis , Aromatase Inhibitors/pharmacology , Breast Neoplasms/pathology , Computer-Aided Design , Drug Design , Molecular Docking Simulation , Nitriles/chemical synthesis , Nitriles/pharmacology , Triazoles/chemical synthesis , Triazoles/pharmacology , Cell Proliferation/drug effects , Cell Survival/drug effects , Dose-Response Relationship, Drug , Female , Humans , Inhibitory Concentration 50 , Letrozole , MCF-7 Cells , Molecular Structure , Structure-Activity Relationship
4.
Eur J Med Chem ; 87: 759-64, 2014 Nov 24.
Article in English | MEDLINE | ID: mdl-25310714

ABSTRACT

A series of 3,6-diphenylimidazo[2,1-b]thiazol-5-amine derivatives was synthesized and evaluated as potential inhibitors of 15-lipoxygenase. Among the synthesized compounds, 5i bearing 2,4,4-trimethylpentan-2-yl pendent group was the most active compound, being two times more potent than reference drug quercetin. Also, the docking study revealed that 5i interacts properly with target enzyme 15-LOX and hydrophobic interactions have important role in the binding process. Besides, the protective effect of 5i against oxidative stress-induced cell death in differentiated PC12 cells was evaluated. The results showed that compound 5i significantly protected PC12 cells against H2O2-induced cell death at concentrations less than 10 µM.


Subject(s)
Arachidonate 15-Lipoxygenase/drug effects , Imidazoles/pharmacology , Lipoxygenase Inhibitors/pharmacology , Thiazoles/pharmacology , Animals , Imidazoles/chemistry , Lipoxygenase Inhibitors/chemistry , Magnetic Resonance Spectroscopy , Molecular Docking Simulation , PC12 Cells , Rats , Thiazoles/chemistry
5.
Expert Opin Drug Discov ; 9(3): 255-67, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24483845

ABSTRACT

INTRODUCTION: In the past, clinical studies had demonstrated that aspirin and NSAIDs reduce the risk of colorectal cancer. After the discovery of selective prostaglandin-endoperoxide synthase 2 (PTGS2) inhibitors, the further beneficial effects of celecoxib and some other related structures (coxibs) have been demonstrated in both in vivo and in vitro studies. AREAS COVERED: The authors illustrate the role of prostaglandins following the overexpression of PTGS2 (COX-2) in signaling pathways. The authors elucidate the role of coxibs in cell proliferation, apoptosis, angiogenesis and multi-drug resistance and discuss the molecular mechanisms involved. The authors also present the strong evidence related to the usefulness of coxibs in several cancer cell lines. EXPERT OPINION: There have been a number of PTGS2 (COX-2) selective inhibitors suggested as potential anticancer therapies. In recent years, the development of nanotechnology has also had an impact on chemotherapy. Indeed, nanoparticles of cytotoxic drug carriers have demonstrated potential through their accumulation in cancer cells, and targeting these nanoparticles has been under evaluation. This area could be opened up for coxib development as they are potentially important targets in cancer cells. Further research using celecoxib as a co-drug with PTGS2-overexpressed and PTGS2-independent cancer is still needed.


Subject(s)
Antineoplastic Agents/therapeutic use , Cyclooxygenase 2 Inhibitors/therapeutic use , Neoplasms/drug therapy , Animals , Antineoplastic Agents/adverse effects , Antineoplastic Agents/pharmacology , Apoptosis , Cyclooxygenase 2/metabolism , Cyclooxygenase 2 Inhibitors/adverse effects , Cyclooxygenase 2 Inhibitors/pharmacology , Drug Resistance, Multiple , Humans , Neoplasms/metabolism , Neoplasms/pathology , Neovascularization, Pathologic/drug therapy , Neovascularization, Pathologic/metabolism , Neovascularization, Pathologic/pathology , Neovascularization, Pathologic/prevention & control , Prostaglandin-Endoperoxide Synthases/metabolism , Prostaglandins/metabolism
6.
Med Chem ; 11(1): 69-76, 2014.
Article in English | MEDLINE | ID: mdl-23638926

ABSTRACT

In this study, the synthesis, anti-inflammatory and analgesic activities of eight new 5-thioalkyl-1,3-diaryl-1,2,4- triazole derivatives were reported. For the anti-inflammatory study, the carrageenan-induced rat paw edema model was used. The test compounds in 50 mg/kg and 100 mg/kg were injected as IP and paw edema was determined. The results showed that some of the compounds have good activity compared to the references drug, indomethacin. For analgesic activity, the test compounds were studied using the in Tail-flick test model in 50 and 100 mg/kg as IP injections. Their analgesic activities were determined after 30 min via latency time assay. Statistical analysis showed that all test compounds have antinociceptive activity in the range of 24% -47% as compared to the control with a dose of 50 mg/kg. However, all tested compounds have analgesic activity lower than the standard drug, morphine.


Subject(s)
Analgesics/chemistry , Anti-Inflammatory Agents/chemistry , Edema/drug therapy , Pain/drug therapy , Triazoles/chemistry , Analgesics/chemical synthesis , Analgesics/pharmacology , Animals , Anti-Inflammatory Agents/chemical synthesis , Anti-Inflammatory Agents/pharmacology , Carrageenan , Edema/chemically induced , Edema/physiopathology , Hindlimb , Indomethacin/pharmacology , Injections, Intraperitoneal , Male , Mice , Morphine/pharmacology , Pain/physiopathology , Rats , Rats, Wistar , Triazoles/chemical synthesis , Triazoles/pharmacology
7.
Daru ; 21(1): 34, 2013 May 01.
Article in English | MEDLINE | ID: mdl-23635011

ABSTRACT

BACKGROUND AND THE PURPOSE OF THE STUDY: Modified androsterone derivatives are class of steroidal compounds with potential anticancer properties. Various steroidal derivatives containing substitution at position 16 have shown diversified pharmacological activities. In the present study, a new series of cytotoxic 16-(substituted benzylidene) derivatives of dehydroepiandrosterone (DHEA) were synthesized and evaluated against three different cancer cell lines. METHODS: The cytotoxic 16-(substituted benzylidene) derivatives of DHEA were synthesized via aldol condensation of DHEA with corresponding benzaldehyde derivatives. The cytotoxic activity of synthesized derivatives was evaluated against three different cancer cells including KB, T47D and SK-N-MC cell lines by MTT reduction colorimetric assay. RESULTS: The results indicated that 16-(substituted benzylidene) derivatives of DHEA could be served as a potent anti-cancer agent. The 3-cholro benzylidene derivatives of DHEA was the most potent synthesized derivative especially against KB and T47D cell lines (IC50 values were 0.6 and 1.7 µM; respectively). CONCLUSION: The cytotoxic potential of novel benzylidene derivatives of DHEA is mainly attributed to the position and nature of the substituted group on the benzylidene pendant.

8.
Iran J Pharm Res ; 12(4): 705-19, 2013.
Article in English | MEDLINE | ID: mdl-24523750

ABSTRACT

Caffeic acid phenethyl ester (CAPE) suppresses the growth of transformed cells such as human breast cancer cells, hepatocarcinoma , myeloid leukemia, colorectal cancer cells, fibrosarcoma, glioma and melanoma. A group of heterocyclic esters of caffeic acid was synthesized using Mitsunobu reaction and the esters were subjected to further structural modification by electrooxidation of the catechol ring of caffeic acid esters in the presence of sodium benzenesulfinate and sodium toluensulfinate as nucleophiles. Both heterocyclic esters of caffeic acid and their arylsulfonyl derivatives were evaluated for their cytotoxic activity against HeLa, SK-OV-3, and HT-29 cancer cell lines. HeLa cells showed the highest sensitivity to the compounds and heterocyclic esters with no substituent on catechol ring showed better activity compared to their substituted counterparts. QSAR studies reemphasized the importance of molecular shape of the compounds for their cytotoxic activity.

9.
Arch Pharm (Weinheim) ; 344(3): 178-83, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21384417

ABSTRACT

A series of 5-nitroimidazole-based 1,3,4-thiadiazoles were prepared and tested for antibacterial activity against Helicobacter pylori. The anti-H. pylori activity of target compounds along with the commercially available antimicrobial metronidazole was evaluated by comparing the inhibition-zone diameters determined by the paper disc diffusion bioassay. From our bioassay results against 20 clinical isolates it is evident that piperazinyl, 4-methylpiperazinyl, 3-methylpiperazinyl, and 3,5-dimethylpiperazinyl analogs (6a, 6b, 6e, and 6f, respectively) and pyrrolidine derivative 7 had strong activity at 0.5 µg/disc (average of inhibition zone > 20 mm) while metronidazole had no activity at this dose. Compound 6f containing the 3,5-dimethylpiperazinyl moiety at the 2-position of the 5-(1-methyl-5-nitro-1H-imidazol-2-yl)-1,3,4-thiadiazole skeleton was the most potent compound tested at low concentrations.


Subject(s)
Anti-Bacterial Agents/pharmacology , Helicobacter pylori/drug effects , Thiadiazoles/pharmacology , Anti-Bacterial Agents/chemical synthesis , Anti-Bacterial Agents/chemistry , Dose-Response Relationship, Drug , Metronidazole/pharmacology , Microbial Sensitivity Tests , Nitroimidazoles/chemical synthesis , Nitroimidazoles/chemistry , Nitroimidazoles/pharmacology , Structure-Activity Relationship , Thiadiazoles/chemical synthesis , Thiadiazoles/chemistry
10.
Reprod Sci ; 17(8): 748-53, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20595706

ABSTRACT

Side effect assessment of medicaments on fertility indices may be used as a guide in the development of male contraceptive agents. In this study, 3 analogs of pyrimethamine were synthesized and evaluated for antifertility activity on reproductive indices of male rats. Test compounds were administered in a dosage of 50 mg/kg every other day till 60 days. On the 50th day, the fertility of rats was tested. On the 60th day, the gonadosomatic index and the serum testosterone content were determined. Iso-butyloxy and tertiary-butyloxy caused 40% and 11% reduction in sperm viability, respectively. They also significantly reduced fertility indices. Consequently, iso-butyloxy can be one of the best nominees in this class of compound and a suitable candidate for assessment of mechanism involved in future research activity. To synthesize a more effective agent, increasing the lipophilicity may play a major role in the development of more potent promising male contraceptive agents.


Subject(s)
Contraceptive Agents, Male/chemical synthesis , Contraceptive Agents, Male/therapeutic use , Fertility/drug effects , Pyrimethamine/analogs & derivatives , Animals , Contraceptive Agents, Male/chemistry , Drug Design , Male , Pyrimethamine/chemical synthesis , Pyrimethamine/chemistry , Pyrimethamine/therapeutic use , Rats , Rats, Sprague-Dawley
SELECTION OF CITATIONS
SEARCH DETAIL
...